Results: 57

Correlation between cellular expression of complement regulatory proteins with depletion and repopulation of B-lymphocytes in peripheral blood of patients with rheumatoid arthritis treated with rituximab

Rev. bras. reumatol; 57 (5), 2017
Abstract Objectives: To correlate the basal expression of complement regulatory proteins (CRPs) CD55, CD59, CD35, and CD46 in B-lymphocytes from the peripheral blood of a cohort of 10 patients with rheumatoid arthritis (RA) initiating treatment with rituximab (RTX) with depletion and time repopulation o...

Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country

Rev. bras. reumatol; 57 (5), 2017
Abstract Objectives: To evaluate, in an endemic country, the long-term efficacy of latent tuberculosis infection (LTBI) screening and primary prophylaxis in patients with JIA receiving TNF blockers. Methods: This was a retrospective cohort that included JIA patients eligible to anti-TNF therapy. Patien...

Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia

Rev. bras. reumatol; 57 (5), 2017
Abstract Objective: To compare DMARD use in patients with and without FM over time, including overtreatment and undertreatment rates in both groups. Methods: A prospective cohort study with patients attending an RA outpatient clinic was conducted. Participants were consecutively recruited between March...

Perioperative management of drugs commonly used in patients with rheumatic diseases: a review

Clinics; 72 (6), 2017
Rheumatic diseases are very prevalent, affecting about 7 million people in North America; they affect the musculoskeletal system, often with systemic involvement and potential for serious consequences and limitation on quality of life. Clinical treatment is usually long-term and includes drugs that are c...

Acute generalized exanthematous pustulosis induced by hydroxychloroquine: a case with atypical clinical presentation

An. bras. dermatol; 92 (3), 2017
Abstract Acute generalized exanthematous pustulosis is a rare drug-induced eruption that is characterized by acute, nonfollicular sterile pustules on an erythematous and edematous base. The most frequently implicated drugs are beta-lactam antibiotics. Hydroxychloroquine has been widely used to treat derm...

Impact of rheumatoid arthritis in the public health system in Santa Catarina, Brazil: a descriptive and temporal trend analysis from 1996 to 2009

Rev. bras. reumatol; 57 (3), 2017
ABSTRACT Introduction: There are few studies that carried out a descriptive and trend analysis based on available data from the Unified Health System (SUS) between pre- and post-free dispensing of pharmacological treatment of rheumatoid arthritis (RA) from the perspective of the public health system, in...

Tormenta de citoquinas: reacción adversa inhabitual por rituximab. caso clínico

Rev. méd. Chile; 145 (2), 2017
Rituximab is a plausible alternative first-line treatment of ANCA-associated vasculitis. Adverse effects related to its infusion are common and usually have a benign course. However, there have been reports of refractory cardiogenic shock simulating septic shock. We report an 81-year-old male with the di...

Tofacitinibe para o tratamento de pacientes adultos com artrite reumatoide ativa moderada a grave com resposta inadequada a um ou mais medicamentos modificadores do curso da doença

Contexto: A AR é uma doença crônica e progressiva, caracterizada pela inflamação da membrana sinovial das articulações. Observa-se um infiltrado linfocítico nas regiões perivasculares e proliferação de células, com consequente angiogênese, hiperplasia sinovial e formação de pannus que lev...

Abatacepte para o tratamento da artrite reumatoide moderada a grave após falha aos MMCDs sintéticos

Contexto: A artrite reumatóide (AR) é uma doença autoimune inflamatória e crônica, caracterizada por sinovite periférica e manifestações extra-articulares. De acordo com o Protocolo Clínico e Diretrizes Terapêuticas (PCDT) da Artrite Reumatoide, o tratamento terapêutico deve ser iniciado com o...

Systemic and localized infection by Candida species in patients with rheumatic diseases receiving anti-TNF therapy

Rev. bras. reumatol; 56 (6), 2016
ABSTRACT Objective: To evaluate the prevalence of systemic and localized infection by Candida species and its possible association with demographic, clinical and laboratory manifestations and therapy in patients with rheumatic diseases taking TNF blockers. Methods: Consecutive patients with rheumatic d...